Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the <i>TRIB2</i> and <i>ABCB6</i> genes-Reference-Cited by-同舟云学术

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes

Published:2022-06-13 Issue:11 Volume:6 Page:3551-3555
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Stomper Julia¹^ORCID,Richter-Pechanska Paulina²,Pfeifer Dietmar¹,Andolfo Immacolata³⁴,Iolascon Achille³⁴,Muckenthaler Martina U.²,Lübbert Michael¹^ORCID

Affiliation:

1. 1Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany;

2. 2Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Hopp Children's Cancer Center at NCT, Heidelberg, Germany;

3. 3Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli ‘Federico II’, Napoli, Italy; and

4. 4CEINGE Biotecnologie Avanzate, Napoli, Italy

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/6/11/3551/1901407/advancesadv2021006277.pdf

Reference24 articles.

1. Deferasirox treatment interruption in a transfusion-requiring myelodysplastic patient led to loss of erythroid response;Breccia;Acta Haematol.,2010

2. Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients;Oliva;Transfusion.,2010

3. Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes;Gattermann;Haematologica.,2012

4. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome;List;J Clin Oncol.,2012

5. Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?;Di Veroli;Leuk Res.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deferasirox;Reactions Weekly;2022-07